Hadi Karami

10PUBLICATIONS
1CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2026
Overcoming ABT-737 resistance in triple-negative breast cancer: C-phycocyanin-mediated myeloid cell leukemia-1 downregulation enhances apoptotic sensitivity.

|Dec 11, 2025
The Isoflavone Formononetin Suppresses Hallmarks of Glioblastoma Progression and Activates a Compensatory Antioxidant Pathway.

Fatemeh Dinarvand, Mehdi Salehi, Seyyed Amirhossein Latifi

|Jul 28, 2022
Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells.

Behzad Baradaran, Roya Nazmabadi, Zohreh Ariyan

|Dec 30, 2021
Combination Therapy with PIK3R3-siRNA and EGFR-TKI Erlotinib Synergistically Suppresses Glioblastoma Cell Growth In Vitro.

Razieh Amini, Hadi Karami, Mohammad Bayat

|Jul 28, 2021
MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells.

Nooshin Ashofteh, Razieh Amini, Neda Molaee

|Jun 28, 2020
MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line.

Vahab Alamdari-Palangi, Zahra Karami, Hadi Karami

Pageof 2

Frequent Collaborators

2 joint publications

Neda Molaee